Utilizing Two Electrokinetic Techniques on a Single Device for Detection of Extracellular Vesicle‐Associated Protease Activity
Authors:
- Ella StimsonESElla Stimson
- Delaney SheaDSDelaney Shea
- Michelle M. GomesMGMichelle M. Gomes
- Srivathsan RanganathanSRSrivathsan Ranganathan
- Sarah MitchellSMSarah Mitchell
- Jason WareJWJason Ware
- Randall ArmstrongRARandall Armstrong
- Christian RossCRChristian Ross
- Michael HellerMHMichael Heller
- Stuart D. IbsenSIStuart D. Ibsen
Open Access
Abstract
Protease activity is an emerging biomarker for cancer detection as activity levels are often increased in tumor tissue compared to healthy tissue. Of particular interest is the activity of proteases carried by extracellular vesicle (EV) nanoparticles which are oversecreted by tumors into circulation. Current methods to analyze the activity of proteases bound to EVs require complex multi‐instrument sample processing to separate EVs from plasma to quantify protease activity. This makes EV‐based protease activity detection a challenge for diagnostic or point‐of‐care applications. Here, a method is reported that manipulates EV nanoparticles and charged molecular byproducts from protease activity using two different electrokinetic phenomena generated by a single electrode microarray within a microfluidic channel. Dielectrophoresis is first generated to recover EVs carrying active trypsin‐like proteases from human plasma followed by electrophoresis for subsequent analysis of peptide cleavage products indicating protease activity. This method demonstrates signal amplification through protease catalytic activity in combination with concentrating mechanisms of dielectrophoresis and electrophoresis. Using this approach, a significant difference in protease activity is observed between patients with pancreatic cancer and benign cysts. This demonstrates dual‐electrokinetic chip‐based technology as a useful tool to manipulate different sized and charged analytes in a single device enabling future clinical translation of EV‐based protease diagnostics.Keywords
Funding Information
- Cancer Early Detection Advanced Research Center, Knight Cancer Institute, Oregon Health and Science University (Exploratory 2022‐1331)
- National Cancer Institute (R37CA258787)
This publication has 36 references indexed in Scilit:
- cyc‐DEP: Cyclic immunofluorescence profiling of particles collected using dielectrophoresisElectrophoresis, 2022
- Theoretical and experimental analysis of negative dielectrophoresis‐induced particle trajectoriesElectrophoresis, 2022
- Dielectrophoresis: Developments and applications from 2010 to 2020Electrophoresis, 2020
- Exosomes, new biomarkers in early cancer detectionAnalytical Biochemistry, 2019
- Increased PSA expression on prostate cancer exosomes in in vitro condition and in cancer patientsCancer Letters, 2017
- Dielectrophoresis2017
- Thrombin generation assay in untreated whole human bloodElectrophoresis, 2016
- Electrophoresis2010
- Role of Proteases in Pancreatic CarcinomaWorld Journal of Surgery, 2005
- Molecular mechanisms for the conversion of zymogens to active proteolytic enzymesProtein Science, 1998